Evidence map›Paper›PMID 31640760›Full record

ArticleJournal of ovarian research2019

MiRNA-802 suppresses proliferation and migration of epithelial ovarian cancer cells by targeting YWHAZ.

Bo Yang, Li Sun, Lei Liang

Open access · goldAbstract read
In one paragraph

Article in Journal of ovarian research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. A bioinformatics approach to identify potential biomarkers of high-grade ovarian cancer.Journal of the Turkish German Gynecological Association · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Dysfunction of miR-802 in tumors.Journal of clinical laboratory analysis · 2021
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Bo YangDepartment of Obstetrics and Gynecology, Bethune International Peace Hospital, 398 Zhongshan West Road, Shijiazhuang, 050000, Hebei Province, China. xnkiwbexxj4@163.com.
Li SunDepartment of Obstetrics and Gynecology, Bethune International Peace Hospital, 398 Zhongshan West Road, Shijiazhuang, 050000, Hebei Province, China.
Lei LiangDepartment of Obstetrics and Gynecology, Bethune International Peace Hospital, 398 Zhongshan West Road, Shijiazhuang, 050000, Hebei Province, China.
Bethune International Peace Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe imbalance of expression of microRNA-802 may have a significant place in tumor progression. However, the bio-function of epithelial ovarian cancer cells remains unclear. Therefore, we setup this study to explore the pathogenesis of epithelial ovarian cancer based on microRNA-802.

methodsRT-qPCR analysis was used to measure the expression level of microRNA802 and YWHAZ in epithelial ovarian cancer. CCK-8, colony formation, flow cytometry and transwell assay were used to detect the effects of microRNA-802 on cell proliferation, apoptosis, invasion and migration. Target gene prediction and screening, luciferase reporting experiments were applied to validate the downstream target genes of microRNA-802. The effects of microRNA-802 on the expression of YWHAZ and its biological effects were measured by Western blotting and RT-qPCR.

resultsCompared with normal cell lines and tissues, the expression level of microRNA-802 was obviously down-regulated in cancer related cell lines and tissues. Overexpression of microRNA-802 could obviously inhibit the invasion and proliferation and induce apoptosis. In addition, YWHAZ was the binding target protein of miR-802 for epithelial ovarian cancer cells. YWHAZ was obviously up-regulated in human epithelial ovarian cancer cells, and YWHAZ was negatively correlated with the expression of miR-802. YWHAZ can partly eliminate the inhibitory effect caused by overexpression of miR-802 on growth and metastasis of epithelial ovarian cancer cells.

conclusionmiR-802 can regulate the occurrence and development of epithelial ovarian cancer by targeting YWHAZ.

Indexed as

Gene Expression Regulation, NeoplasticRNA Interference14-3-3 Proteins3' Untranslated RegionsApoptosisCarcinoma, Ovarian EpithelialCell Line, TumorCell MovementCell ProliferationFemaleHumansMicroRNAsOvarian Neoplasms14-3-3 Proteins3' Untranslated RegionsMicroRNAsMIRN802 microRNA, humanYWHAZ protein, humanEpithelial ovarian cancerMetastasismiR-802ProliferationYWHAZ

Identifiers

PMID31640760
PMCPMC6806521
OpenAlexW2982226223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.